Advertisement

Ads Placeholder
Loading...

Haleos Labs Limited

HALEOSLABS.BOBSE
Healthcare
Biotechnology
1299.00
45.20(3.61%)
Indian Market opens in 34h 48m

Haleos Labs Limited (HALEOSLABS.BO) Stock Overview

Explore Haleos Labs Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio21.00
EPS (TTM)$65.61
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$1423.21
3 Months$1978.62
1 Year TargetN/A

HALEOSLABS.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleos Labs Limited (HALEOSLABS.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.00 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.61%
5-Day Change
3.89%
1-Month Change
0.34%
3-Month Change
-2.97%
6-Month Change
10.77%
Year-to-Date (YTD) Change
-2.97%
1-Year Change
7.36%
3-Year Change
150.99%
5-Year Change
163.84%
All-Time (Max) Change
774.16%

Contact Information

91 40 6628 8888
Plot No. 19-III, Hyderabad, NaN, 500096

Company Facts

5,920 Employees
IPO DateAug 21, 2017
CountryIN
Actively Trading

Frequently Asked Questions